On Tuesday, July 11, 2023, the RINK Public Forum was held at the Life Innovation Center under the joint cooperation of the Kanagawa Prefectural Government （KPG）, RINK, and Merck KGaA.
After an explanation of the policy by KPG, Dr. Edmund Ang of Merck KGaA gave a lecture on the impact of the revision of ICH Q5A(R2) on cell and gene therapy products. The seminar was a success with a valuable lecture and a lively Q&A session.
